Food and Drug Administration (FDA) approved drugs donepezil, rivastigmine, tacrine and galantamine are AChE inhibitors and in the treatment of Alzheimer’s disease (AD) these drugs are currently prescribed. This evidence concerns the gene ACHE and early-onset autosomal dominant Alzheimer disease.